Apyx Medical Corp

Apyx Medical Corp designs, develops, manufactures, and sells electrosurgical equipment and medical devices, with a particular focus on its helium plasma technology platform. The company serves both OEM customers and physicians in the surgical aesthetics market, where it markets devices used in cosmetic and certain surgical procedures. Its product set has expanded from core generators and handpieces to newer systems such as the Apyx One Console and the Renuvion Micro Handpiece. Apyx also manufactures products for third-party medical device companies under OEM agreements, including a long-term supply arrangement with Symmetry Surgical. The business is centered in the United States but operates with international manufacturing and distribution support, including production in Bulgaria and sales outside the U.S.

−11,0 %

62,5 %

−21,2 %

+9,9 %

5.00

4.26

— Apyx Medical Corp
%
Surgical Aesthetics Systems55% Energy-based devices and consoles used by plastic, cosmetic, and related surgeons for soft tissue contraction and aesthetic procedures.
OEM Manufacturing25% Generators, devices, and accessories produced for third-party medical device manufacturers under supply agreements.
Handpieces and Consumables15% Single-use or procedure-linked handpieces and accessories used with the company's energy platforms.
Other Specialty Surgical Products5% Opportunistic specialty products sold to niche medical device customers outside the core aesthetics focus.

Apyx sells primarily to physicians and surgeons in cosmetic and surgical aesthetics, especially plastic and cosmetic...

  • Plastic and cosmetic surgeonsprimary

    Buy consoles, handpieces, and accessories for elective aesthetic procedures because the technology supports their practice mix and procedure economics.

  • OEM medical device manufacturersprimary

    Purchase generators, devices, and accessories under supply agreements to outsource production and access Apyx's electrosurgical expertise.

  • Start-up medtech companiessecondary

    Use Apyx for energy-based design and manufacturing support when they need a development partner with electrosurgical know-how.

  • International distributor channelsecondary

    Buys or resells products into non-U.S. markets to extend the reach of the surgical aesthetics platform.

Apyx is headquartered in the United States and manufactures most of its products in Clearwater, Florida, while also...

  • United States is the core market for surgical aesthetics sales and OEM activity
  • Clearwater, Florida is a key manufacturing site and operational hub
  • Sofia, Bulgaria supports manufacturing and supply-chain redundancy
  • International distributors extend sales into non-U.S. markets
  • Outside-U.S. growth has included cosmetic surgery and surgical oncology uses
  • Florida weather exposure can disrupt production and customer fulfillment

Apyx is prioritizing its Surgical Aesthetics segment, where management believes the market is larger and margins are...

01
Grow Surgical Aesthetics adoptionshort-term

This is the company's core growth engine and the segment management believes offers the best margin profile.

02
Launch and refine new product platformsmedium-term

New devices expand use cases, improve usability, and help defend the platform against competing energy-based systems.

03
Reduce reliance on OEM revenuemedium-term

Management expects OEM revenue to decline as the company reallocates resources to higher-value aesthetics opportunities.

Apyx faces demand risk because a large part of its business depends on discretionary cosmetic and aesthetic procedures,...

high

Weak discretionary demand for cosmetic and aesthetic procedures

The core Surgical Aesthetics business depends on elective spending by patients and physician purchasing decisions, which are sensitive to macro conditions.

Scope
Surgical Aesthetics segment
Materiality
high
high

Regulatory clearance or approval delays

New products and expanded indications require regulatory success before commercialization, so delays can defer revenue and increase development expense.

Scope
Product pipeline and new launches
Materiality
high
high

Supply-chain disruption and single-source dependence

The company relies on outsourced components and single-source suppliers, which can interrupt manufacturing and customer fulfillment.

Scope
Manufacturing and OEM supply
Materiality
high
medium

Hurricane and weather disruption in Clearwater, Florida

A key manufacturing facility is located in a weather-exposed region, creating operational and inventory risk.

Scope
Production and logistics
Materiality
medium
medium

OEM customer order volatility

OEM customers have no legal obligation to continue purchasing after development, making this revenue stream less durable.

Scope
OEM segment
Materiality
medium
Revenue recognition by business line
Can shift reported revenue and gross margin timing
Inventory valuation and obsolescence
Can affect cost of sales and operating results
Equity financing and dilution
Impacts EPS and capital structure analysis
Going-concern and liquidity assumptions
Important for solvency and valuation assessment

: 11/08/2026